top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Axonis Therapeutics Secures $115M Series A to Advance Neuromedicine Pipeline

  • Nov 6, 2024
  • 1 min read

Boston, MA, October 30, 2024 (PRNewswire) -- Axonis Therapeutics raised $115 million in Series A funding to advance AXN-027 for epilepsy and pain treatment. Axonis will advance its oral KCC2 pipeline to treat neurological conditions.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments


Life Science Headlines
bottom of page